Literature DB >> 17828606

Liver stage antigen 3 isolated from a cDNA library of Plasmodium falciparum erythrocytic stages.

Eva M Moyano1, Luis Miguel González, Susana Arahuetes, Agustín Benito.   

Abstract

An expression library of P. falciparum erythrocyte stages (clon Dd2) was constructed and immunoscreened with a sera pool from malaria patients. Isolated clones were analysed, and the liver stage antigen 3 (LSA-3) antigen was identified. The partial nucleotide sequence of LSA-3 has 1,623 bp. The open reading frame coded for the putative protein with 541 amino acid residues. We have demonstrated by reverse transcriptase polymerase chain reaction the transcription of the LSA-3 gene in ring form, trophozoite, and schizont, stages of asexual erythrocyte cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828606     DOI: 10.1007/s00436-007-0737-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  18 in total

Review 1.  The past, present and future of childhood malaria mortality in Africa.

Authors:  R W Snow; J F Trape; K Marsh
Journal:  Trends Parasitol       Date:  2001-12

2.  Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.

Authors:  B L Perlaza; J P Sauzet; A T Balde; K Brahimi; A Tall; G Corradin; P Druilhe
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

Review 3.  Genetic diversity in Plasmodium falciparum.

Authors:  D J Kemp; A F Cowman; D Walliker
Journal:  Adv Parasitol       Date:  1990       Impact factor: 3.870

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

Review 5.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden.

Authors:  J G Breman
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.

Authors:  K Brahimi; E Badell; J P Sauzet; L BenMohamed; P Daubersies; C Guérin-Marchand; G Snounou; P Druilhe
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum.

Authors:  M J Gardner; H Tettelin; D J Carucci; L M Cummings; L Aravind; E V Koonin; S Shallom; T Mason; K Yu; C Fujii; J Pederson; K Shen; J Jing; C Aston; Z Lai; D C Schwartz; M Pertea; S Salzberg; L Zhou; G G Sutton; R Clayton; O White; H O Smith; C M Fraser; M D Adams; J C Venter; S L Hoffman
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A developmental defect in Plasmodium falciparum male gametogenesis.

Authors:  F Guinet; J A Dvorak; H Fujioka; D B Keister; O Muratova; D C Kaslow; M Aikawa; A B Vaidya; T E Wellems
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

View more
  2 in total

Review 1.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

Review 2.  Vaccine candidate discovery for the next generation of malaria vaccines.

Authors:  James Tuju; Gathoni Kamuyu; Linda M Murungi; Faith H A Osier
Journal:  Immunology       Date:  2017-07-24       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.